• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

910133-70-9 ((1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5-cyclopropyl-5-hydroxypent-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol)

1

Identification

Smiles O[[email protected]](C/C1=C\C=C2[[email protected]@](CC[[email protected]@H]3[[email protected]@H](/C=C/[[email protected]@H](O)C4CC4)C)([H])[[email protected]]3(C)CCC\2)C[[email protected]](O)C1=C
Synonyms
InChI InChI=1S/C27H40O3/c1-17(6-13-25(29)20-8-9-20)23-11-12-24-19(5-4-14-27(23,24)3)7-10-21-15-22(28)16-26(30)18(21)2/h6-7,10,13,17,20,22-26,28-30H,2,4-5,8-9,11-12,14-16H2,1,3H3/b13-6+,19-7+,21-10+/t17-,22-,23-,24+,25-,26+,27-/m1/s1
2

Introduction

Background Information

Calcipotriol Impurity C, the trans-isomeric impurity of Calcipotriene, is an analogue of VD3 which could be an agonist of vitamin D receptor. ......by BOC Sciences
Calcipotriol Impurity C is the impurity of Calcipotriol, Calcipotriol is a ligand of VDR-like receptors. Target: VDR ......by MedChemexpress Co., Ltd.
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance:White to off-white solid EBNumber:EB000020076

Storage condition

4°C, protect from light, stored under nitrogen by MedChemexpress Co., Ltd.

Solubility

10 mM in DMSO by MedChemexpress Co., Ltd.
5

Mechanism and Indication

Signaling Pathways Others
Target VD/VDR
Research Area Inflammation/Immunology
Indications
6

Clinical Information

7

Safety Data of (1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5-cyclopropyl-5-hydroxypent-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol

8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
BOC Sciences
CHEMSCENE, LLC 500mg/USD1650(In stock) USA
MedChemexpress Co., Ltd. 500mg/USD1650(In stock) USA
Shanghai Haoyuan Chemexpress Co., Ltd. 500mg/USD1650(In stock) China
10

Related Products

Other Forms of 910133-70-9

Name CAS No Formula MW

Recommended Compounds in VD/VDR

Name CAS No Formula MW
25,26-Dihydroxyvitamin D3 29261-12-9 C27H44O3 416.64
(24R)-MC 976 112828-09-8 C27H42O3 414.62
(24S)-24,25-Dihydroxyvitamin D3 55700-58-8 C27H44O3 416.64
Calcitriol Impurities D 103656-40-2 C28H46O3 430.663
Calcifediol (monohydrate) 63283-36-3 C27H44O2 400.64
Cholecalciferol 67-97-0 C27H44O 384.64
(24S)-MC 976 112849-14-6 C27H42O3 414.62
(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((Z)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol C39H68O3Si2 641.1264
VD3-D6 118584-54-6 C27H38D6O 390.67
VD2-D3 1217448-46-8 C28H41D3O 399.67
25-Hydroxy VD2-D6 1262843-46-8 C28H38D6O2 418.68
1alpha, 25-Dihydroxy VD2-D6 216244-04-1 C28H38D6O3 434.68
Calcipotriol (monohydrate) 147657-22-5 C27H42O4 430.62
Cholecalciferol 67-97-0 C27H44O 384.63766
Calcitriol Impurities A 73837-24-8 C27H44O3 416.6365
Paricalcitol 131918-61-1 C27H44O3 416.64
MC 976 129831-99-8 C27H42O3 414.62
24R-Calcipotriol 112827-99-3 C27H40O3 412.6
MC 1046 126860-83-1 C27H38O3 410.59
3-O-(2-Aminoethyl)-25-hydroxyvitamin D3 163018-26-6 C30H51NO2 457.73

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

Protocol Reference

13

More Information

(1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5-cyclopropyl-5-hydroxypent-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol

Tags: buy 910133-70-9 IC50 | 910133-70-9 price | 910133-70-9 cost | 910133-70-9 solubility | 910133-70-9 purchase | 910133-70-9 manufacturer | 910133-70-9 research buy | 910133-70-9 order | 910133-70-9 MSDS | 910133-70-9 chemical structure | 910133-70-9 Storage condition | 910133-70-9 molecular weight | 910133-70-9 mw | 910133-70-9 datasheet | 910133-70-9 supplier | 910133-70-9 cell line | 910133-70-9 NMR | 910133-70-9 MS | 910133-70-9 IR | 910133-70-9 solubility | 910133-70-9 Safe information | 910133-70-9 Qc and Spectral Information | 910133-70-9 Clinical Information | 910133-70-9 Clinical Trial | 910133-70-9 Route of Synthesis | 910133-70-9 storage condition | 910133-70-9 diseases and conditions | 910133-70-9 flash point | 910133-70-9 boiling point | 910133-70-9 melting point | 910133-70-9 storage condition | 910133-70-9 brand